Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 2885 of 5804
-
New hope for Hard-to-Treat prostate cancer: early trial launches
Disease control Recruiting nowThe overall aim of the trial is to evaluate the safety, tolerability, and pharmacokinetics (PK) of AMG 509 (monotherapy and in combination with abiraterone acetate and enzalutamide) and to evaluate preliminary efficacy. As of Protocol Amendment 10 (09 July 2025), only Parts 4A ex…
Phase: PHASE1 • Sponsor: Amgen • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
New hope for rare bone cancer: targeted drug AG-120 tested in small trial
Disease control OngoingThis study is being done to see whether AG-120 is an effective and safe treatment for people with advanced/metastatic or recurrent chondrosarcoma that has IDH1 mutation.
Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
New drug ARO-HSD tested for fatty liver disease NASH
Disease control CompletedThe purpose of this study is to evaluate the safety, tolerability, pharmacokinetics (PK) and pharmacodynamics of single and multiple doses of ARO-HSD in healthy adult volunteers and in patients with NASH or suspected NASH.
Phase: PHASE1, PHASE2 • Sponsor: Arrowhead Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 07:53 UTC
-
Can collagen and hyaluronic acid boost rotator cuff repair?
Disease control OngoingThe purpose of this study is to analyze the correlation between the synergistic effects of atelocollagen and hyaluronic acid (HA) in enhancing rotator cuff healing postoperatively in patients undergoing rotator cuff repair surgery.The main questions it aims to answer are: * Does…
Phase: NA • Sponsor: Hallym University Dongtan Sacred Heart Hospital • Aim: Disease control
Last updated Jun 27, 2026 09:04 UTC
-
New filter may protect tiny blood vessels during heart surgery
Disease control CompletedOxiris membrane is an efficient tool for inflammatory cytokines adsorption. Cardiac surgery is followed by an inflammatory state mimicking sepsis. The investigators hypothesized that cytokine adsorption by Oxiris® membrane can attenuate the inflammatory response and thus decrease…
Phase: NA • Sponsor: Centre Hospitalier Universitaire, Amiens • Aim: Disease control
Last updated Jun 26, 2026 18:43 UTC
-
Sleep therapy shows promise for veterans battling PTSD and insomnia
Symptom relief CompletedThe purpose of this study is to determine whether a behavioral sleep treatment improves functioning and sleep in Veterans with posttraumatic stress disorder (PTSD).
Phase: PHASE2 • Sponsor: VA Office of Research and Development • Aim: Symptom relief
Last updated Jun 27, 2026 11:00 UTC
-
New scan could sharpen bladder cancer staging
Diagnosis CompletedThis research study is studying a positron emission tomography (PET) agent called 18F-fluciclovine to evaluate how well 18F-fluciclovine-PET scans determine the extent of muscle invasive bladder cancer (as compared to regular CT and MRI imaging) and whether 18F-fluciclovine-PET s…
Phase: EARLY_PHASE1 • Sponsor: Brigham and Women's Hospital • Aim: Diagnosis
Last updated Jun 27, 2026 14:02 UTC
-
New hope for advanced liver cancer: first human trial of ABSK-011 begins
Disease control Recruiting nowThis is an open-label phase 1 study with an escalation part and an expansion part.
Phase: PHASE1 • Sponsor: Abbisko Therapeutics Co, Ltd • Aim: Disease control
Last updated Jun 27, 2026 12:04 UTC
-
Cancer drug may tame sickle cell pain, early study hints
Disease control TerminatedIn this protocol, the investigators propose to evaluate the biochemical effects of imatinib on sickle red blood cells (RBCs). Patients will be administered imatinib mesylate orally following the guidelines previously established for use of imatinib in other disorders. The biochem…
Phase: PHASE1, PHASE2 • Sponsor: Indiana University • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
New hope for aggressive brain tumors? early trial combines two targeted drugs
Disease control OngoingThis is a phase 1 study of atezolizumab in combination with D2C7-IT, a dual-specific monoclonal antibody (mAB) with a high affinity for both EGFRwt- and EGFRvIII-expressing cells, in patients with recurrent World Health Organization (WHO) grade IV malignant glioma at the Preston …
Phase: PHASE1 • Sponsor: Darell Bigner • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New drug cocktail targets Hard-to-Treat breast cancer mutation
Disease control CompletedThis is an open label, single arm, multicenter, phase Ib study to evaluate the safety and clinical activity of the combination of ipatasertib, trastuzumab and pertuzumab in patients with unresectable locally advanced or metastatic HER2-positive breast cancer with tumors harboring…
Phase: PHASE1 • Sponsor: SOLTI Breast Cancer Research Group • Aim: Disease control
Last updated Jun 27, 2026 11:01 UTC
-
Cancer drug niraparib tested before prostate surgery – early trial stopped
Disease control TerminatedThis phase II trial studies how well niraparib, when given before surgery, works in treating patients with high risk prostate cancer that has not spread to other parts of the body (localized) and alterations in deoxyribonucleic acid (DNA) repair pathways. Niraparib may stop the g…
Phase: PHASE2 • Sponsor: University of California, Davis • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC
-
Air purifiers may lower blood pressure in seniors near roadways
Disease control CompletedExposure to fine particulate matter (PM2.5) air pollution is an established risk factor for cardiovascular (CV) morbidity.
Phase: NA • Sponsor: University of Michigan • Aim: Disease control
Last updated Jun 27, 2026 08:11 UTC
-
App aims to curb HIV crisis among young black men in alabama
Prevention CompletedThe overall goal of this 5-year Mentored Research Scientist Development K01-Award is to support Henna Budhwani, PhD, MPH to become an independent implementation science investigator in the field of HIV prevention. The proposed project seeks to address the HIV crisis in Alabama, w…
Phase: NA • Sponsor: Florida State University • Aim: Prevention
Last updated Jun 27, 2026 09:03 UTC
-
Experimental cancer combo trial halted early – what it means for patients
Disease control TerminatedA first-in-human study using BDC-1001 as a single agent and in combination with nivolumab in HER2 expressing advanced malignancies
Phase: PHASE1, PHASE2 • Sponsor: Bolt Biotherapeutics, Inc. • Aim: Disease control
Last updated Jun 26, 2026 17:13 UTC
-
Lifestyle overhaul may rewrite Sperm's epigenetic code
Knowledge-focused OngoingThis is a rigorous, controlled clinical trial designed to show that diet, exercise training, and their combination in overweight, inactive men will alter epigenetic programming to create a "healthy" sperm epigenome. Our central hypotheses are: i) overweight and inactive lifestyle…
Phase: NA • Sponsor: Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:00 UTC
-
Rowing with electric stimulation may ease pain after spinal cord injury
Symptom relief TerminatedSpinal Cord Injury (SCI) leads to alterations in brain structure and function by spinal nerve damage, secondary inflammatory responses, and by the consequences of living with paralysis and neuropathic pain. Physical inactivity due to lower body paralysis rapidly leads to loss of …
Phase: NA • Sponsor: Spaulding Rehabilitation Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 08:09 UTC
-
Gene sleuths hunt for Antibiotic-Resistant bacteria in CF lungs
Knowledge-focused CompletedPulmonary exacerbations (PEx) are key events that lead to a decline in health status among CF patients, with many never recovering to baseline health. With the advancement of new CFTR modulators and other therapies increasing the lifespan of those living with CF, it will become i…
Sponsor: National Jewish Health • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:06 UTC
-
Herbal blend shows promise against COVID-19 in small trial
Disease control CompletedAntiCov-220 prevents and treats before, during, and after infection with SARS-CoV-2. The composition is fractionally extracted from herbs (Ascorbic Acid, L-Arginine hydrochloride, Adenosma glutinosum extract, Eclipta prostrata extract, Phyllanthus urinaria extract, Impatiens bals…
Phase: PHASE4 • Sponsor: Nguyen Thi Trieu, MD • Aim: Disease control
Last updated Jun 26, 2026 16:25 UTC
-
Laughing gas may reveal brain clues for depression
Knowledge-focused CompletedRecent evidence suggest that Nitrous Oxyde (N2O) could exhibit antidepressant effect in treatment-resistant depression (TRD). However, the pathophysiology of this effect remains unclear and could include glutamatergic activity but also cerebrovascular effects and changes in brain…
Phase: NA • Sponsor: University Hospital, Tours • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:05 UTC